The DOI matches its Crossref record.
What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?
Open accessAbstract
The effect of open treatment with coarse wheat bran was compared with response to placebo, given in the form of a double blind, cross over drug trial, in patients with irritable bowel syndrome. Both bran and placebo significantly reduced the severity of most of the symptoms. Constipation was the only symptom that improved significantly with bran, but not with placebo, and was the only symptom that predicted a successful outcome with bran. Diarrhoea did not improve with bran. In fact, stools became less formed in patients presenting with this symptom. The incidence of pain and urgency was significantly more frequent on bran compared with placebo. Compared with a baseline period, bran treatment resulted in an acceleration of whole gut transit time (p less than 0.05) increases in daily stool weight (p less than 0.01) and the proportion of unformed stools (p less than 0.01) but no change in stool frequency. Coarse wheat bran was no better than placebo for most symptoms in irritable bowel syndrome, although its efficacy in constipation was confirmed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Flaxseed—a potential functional food source
Kajla, P., Sharma, A., & Sood, D. R. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-014-1293-y · Cited by 536
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Management of the irritable bowel syndrome
Camilleri, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.21908 · Cited by 343
Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome
Bijkerk, C. J., Muris, J. W. M., Knottnerus, J. A., Hoes, A. W., & De Wit, N. J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.0269-2813.2004.01862.x · Cited by 326
Review article: irritable bowel syndrome
CAMILLERI, M., & CHOI, M. ‐. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.84256000.x · Cited by 290
Role of loperamide and placebo in management of irritable bowel syndrome (IBS)
Cann, P. A., Read, N. W., Holdsworth, C. D., & Barends, D. (1984) · Digestive Diseases and Sciences · doi:10.1007/bf01296258 · Cited by 257
Self-citationQuartero, A. O., Meiniche-Schmidt, V., Muris, J., Rubin, G., & de Wit, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub2 · Cited by 190
ASHRAF, W., PARK, F., LOF, J., & QUIGLEY, E. M. M. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00433.x · Cited by 178
Badiali, D., Corazziari, E., Habib, F. I., Tomei, E., Bausano, G., Magrini, P., Anzini, F., & Torsoli, A. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065421 · Cited by 127
Defining the predictors of the placebo response in irritable bowel syndrome
Pitz, M., Cheang, M., & Bernstein, C. N. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00626-3 · Cited by 111
Vincent, R., Roberts, A., Frier, M., Perkins, A. C., MacDonald, I. A., & Spiller, R. C. (1995) · Gut · doi:10.1136/gut.37.2.216 · Cited by 72
Use of Diet and Probiotic Therapy in the Irritable Bowel Syndrome: Analysis of the Literature
Floch, M. H. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000156104.67505.5b · Cited by 52
Psychological aspects of irritable bowel syndrome
Langeluddecke, P. M. (1985) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048678509158826 · Cited by 48
Preventing constipation: a review of the laxative potential of food ingredients
Gélinas, P. (2013) · International Journal of Food Science & Technology · doi:10.1111/j.1365-2621.2012.03207.x · Cited by 26
Metadata
- Authors
- Cann, P. A., Read, N. W., & Holdsworth, C. D.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1984-02
- Volume
- 25
- Issue
- 2
- Pages
- 168-173
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1982400939
- Cited by
- 173
- References
- 0
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.